comparemela.com

Latest Breaking News On - Pharmetrics plus - Page 1 : comparemela.com

Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study

Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesLeona marksonThromb haemostYong chenSteen carlssonHealth statisticsB international classification of diseasesNational centerPfizer incValue healthWorld federation of hemophiliaInstitute incIntj technol assess health carePfizer ltdPharmetrics plus

Medically, you might be interested in

A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’ – compiled and written by Clare GP Dr Ray O’Connor

United kingdomBurkina fasoUnited statesRay oconnorNutrition examination surveyNurse health studyNational healthUniversity of oxfordHealth professionalsHealth professionals studySerum institute of indiaWorld health organizationGlobal burdenDisease studyRayo connorHealth professionals follow up study

GLP-1 Agonist Use for Weight Loss Linked to Gastrointestinal Adverse Events

Users of GLP-1 agonists for weight loss, compared with bupropion-naltrexone, experienced higher rates of gastrointestinal adverse events.

United statesInternational classification of diseasesPharmetrics plusInternational classification

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Serious side effects add up at a population level, and are more common than those seen for bupropion-naltrexone, authors say.

British columbiaUnited statesMohit sodhiMahyar etminanAmerican heart associationCurrax pharmaceuticalsMsc university of british columbiaNovo nordiskPharmetrics plus

Ozempic-like meds linked to higher risk of pancreatitis, stomach paralysis than other weight-loss drugs

GLP-1 agonists like Ozempic come with a higher risk of severe GI issues than a different common weight-loss drug does.

United kingdomMohit sodhiUniversity of british columbiaBritish columbiaPharmetrics plus

vimarsana © 2020. All Rights Reserved.